Tumor Biology

, Volume 35, Issue 3, pp 1955–1964 | Cite as

Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma

  • Yang Zhao
  • Shuo Chen
  • Wen-feng Gou
  • Li-jun Xiao
  • Yasuo Takano
  • Hua-chuan Zheng
Research Article

Abstract

Beclin 1, an important autophagy-related protein in human cells, is involved in autophagy, differentiation, anti-apoptosis, and cancer suppression, which is increased during periods of cell stress and extinguished during cell cycle. Human ovarian tumors display allelic loss of Beclin 1 with high frequency. To clarify Beclin 1's role in ovarian carcinogenesis and subsequent progression, its expression was examined by immunostaining on tissue microarrays containing ovarian normal tissue, benign and borderline tumors, and carcinomas. Beclin 1 mRNA and protein expression was examined in ovarian normal tissue, benign and borderline tumors, carcinoma tissue, and cell lines by reverse transcription polymerase chain reaction or Western blot, respectively. The results demonstrated that the higher Beclin 1 mRNA was observed in ovarian benign tumor than normal ovary and ovarian carcinoma (P < 0.05) and negatively correlated with the differentiation of ovarian carcinoma (P < 0.05). Beclin 1 protein expression was stronger in ovarian carcinoma than that in normal ovary and inversely related to the differentiation of ovarian carcinoma (P < 0.05) by Western blot. Immunohistochemically, Beclin 1 expression was statistically higher in ovarian borderline tumor and carcinoma than normal ovary and benign tumor (P < 0.05) and inversely linked to differentiation, lower ki-67 expression, and higher cumulative or relapse-free survival rate of ovarian carcinoma (P < 0.05). Cox proportional hazard model indicated that age and International Federation of Gynecology and Obstetrics staging (P < 0.05), but not pathological classification differentiation degree or Beclin 1 expression, were independent prognostic factors for overall and relapse-free ovarian carcinomas (P > 0.05). It was suggested that the aberrant Beclin 1 expression is closely linked to tumorigenesis and differentiation of ovarian carcinoma. Beclin 1 expression might be employed to indicate the worse prognosis of ovarian carcinomas, albeit not an independent factor.

Keywords

Ovarian carcinoma Beclin 1 Pathogenesis Progression Prognosis 

References

  1. 1.
    Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by Beclin 1. Nature. 1999;402:672–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Liang XH, Yu J, Brown K, Levine B. Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res. 2001;61:3443–9.PubMedGoogle Scholar
  3. 3.
    Kang R, Livesey KM, Zeh HJ, Loze MT, Tang D. HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy. 2010;6:1209–11.CrossRefPubMedGoogle Scholar
  4. 4.
    Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18:571–80.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Li H, Wang P, Sun Q, et al. Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res. 2011;71:3625–34.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Zhu Y, Zhao L, Liu L, et al. Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell. 2010;1:468–77.CrossRefPubMedGoogle Scholar
  7. 7.
    Wang ZH, Xu L, Duan ZL, Zeng LQ, Yan NH, Peng ZL. Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells. Gynecol Oncol. 2007;107:107–13.CrossRefPubMedGoogle Scholar
  8. 8.
    John S, Nayvelt I, Hsu HC, et al. Regulation of estrogenic effects by Beclin 1 in breast cancer cells. Cancer Res. 2008;68:7855–63.CrossRefPubMedGoogle Scholar
  9. 9.
    Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100:15077–82.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the Beclin 1 autophagy gene. J Clin Invest. 2003;112:1809–20.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, et al. The autophagy-related protein Beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest. 2008;118:2190–9.PubMedCentralPubMedGoogle Scholar
  12. 12.
    Tannous P, Zhu H, Johnstone JL, et al. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A. 2008;105:9745–50.PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics. 1999;59:59–65.CrossRefPubMedGoogle Scholar
  14. 14.
    Wang ZH, Peng ZL, Duan ZL, Liu H. Expression and clinical significance of autophagy gene Beclin 1 in cervical squamous cell carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006;37:860–3.PubMedGoogle Scholar
  15. 15.
    Shi YH, Ding ZB, Zhou J, Qiu SJ, Fan J. Prognostic significance of Beclin 1-dependent apoptotic activity in hepatocellular carcinoma. Autophagy. 2009;5:380–2.CrossRefPubMedGoogle Scholar
  16. 16.
    Duan ZL, Peng ZL, Wang ZH. Expression and involved signal transduction pathway of autophagy gene Beclin 1in epithelial ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban. 2007;38:239–42.PubMedGoogle Scholar
  17. 17.
    Huang X, Bai HM, Chen L, Li B, Lu YC. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J Clin Neurosci. 2010;17:1515–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Jiang ZF, Shao LJ, Wang WM, Yan XB, Liu RY. Decreased expression of Beclin-1 and LC3 in human lung cancer. Mol Biol Rep. 2012;39:259–67.CrossRefPubMedGoogle Scholar
  19. 19.
    Ahn CH, Jeong EG, Lee JW, et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS. 2007;115:1344–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Okura R, Nakamura M. Overexpression of autophagy-related beclin-1 in cutaneous squamous cell carcinoma with lymph-node metastasis. Eur J Dermatol. 2011;21:1002–3.PubMedGoogle Scholar
  21. 21.
    Kim HS, Lee SH, Do SI, Lim SJ, Park YK, Kim YW. Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma. Pathol Res Pract. 2011;207:247–52.CrossRefPubMedGoogle Scholar
  22. 22.
    Dong LW, Hou YJ, Tan YX, et al. Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma. Autophagy. 2011;7:1222–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Song H, Xia SL, Liao C, et al. Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma. World J Gastroenterol. 2004;10:509–13.PubMedGoogle Scholar
  24. 24.
    Piek JM, van Diest PJ, Verheijen RH. Ovarian carcinogenesis: an alternative hypothesis. Adv Exp Med Biol. 2008;622:79–87.CrossRefPubMedGoogle Scholar
  25. 25.
    Bandera CA. Advances in the understanding of risk factors for ovarian cancer. J Reprod Med. 2005;50:399–406.PubMedGoogle Scholar
  26. 26.
    Zheng H, Tsuneyama K, Cheng C, et al. An immunohistochemical study of p53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray. Anticancer Res. 2006;26:2353–60.PubMedGoogle Scholar
  27. 27.
    Karam AK, Karlan BY. Ovarian cancer: the duplicity of CA125 measurement. Nat Rev Clin Oncol. 2010;7:335–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Li W, Murai Y, Okada E, et al. Modified and simplified western blotting protocol: use of intermittent microwave irradiation (IMWI) and 5% skim milk to improve binding specificity. Pathol Int. 2002;52:234–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol. 2004;17:1141–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 2007;17:839–49.CrossRefPubMedGoogle Scholar
  31. 31.
    Chen YB, Hou JH, Feng XY, et al. Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas. J Surg Oncol. 2012;105:542–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Wang ZH, Xu L, Wang Y, Cao MQ, Li L, Bai T. Clinicopathologic correlations between human papillomavirus 16 infection and Beclin 1 expression in human cervical cancer. Int J Gynecol Pathol. 2011;30:400–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Chen Y, Lu Y, Lu C, Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia- inducible factor (HIF)-1alpha expression. Pathol Oncol Res. 2009;15:487–93.PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Pirtoli L, Cevenini G, Tini P, et al. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy. 2009;5:930–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Wan XB, Fan XJ, Chen MY, et al. Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy. 2010;6:395–404.CrossRefPubMedGoogle Scholar
  36. 36.
    Koukourakis MI, Giatromanolaki A, Sivridis E, Pitiakoudis M, Gatter KC, Harris AL. Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer. 2010;103:1209–14.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Huang JJ, Li HR, Huang Y, et al. Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type. Autophagy. 2010;6:777–83.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Yang Zhao
    • 1
  • Shuo Chen
    • 1
  • Wen-feng Gou
    • 2
  • Li-jun Xiao
    • 2
  • Yasuo Takano
    • 3
  • Hua-chuan Zheng
    • 2
  1. 1.Department of GynecologyThe First Affiliated Hospital of China Medical UniversityShenyangChina
  2. 2.Department of Biochemistry and Molecular Biology, Institute of Pathology and Pathophysiology, College of Basic MedicineChina Medical UniversityShenyangChina
  3. 3.Clinical Cancer InstituteKanagawa Cancer CenterYokohamaJapan

Personalised recommendations